NEUROCHEMICAL RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2230598, encodeId=67292230598d0, content=审稿速度:6.0 偏重的研究方向：神经 经验分享：2024年九月份投的，10月份才找到第一个审稿人，服了，怎么这么慢啊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18a99452737, createdName=ms5000002052969284, createdTime=Sun Oct 13 11:01:18 CST 2024, time=2024-10-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2220216, encodeId=90222220216c9, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：神经相关作用机制 经验分享：审稿较慢，但是修回之后，接受就很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e081658561, createdName=xixixi, createdTime=Thu Aug 15 10:52:03 CST 2024, time=2024-08-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2189283, encodeId=3da5218928320, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：小胶质细胞，脱髓鞘;生物分子学;神经 经验分享： Submission accepted 17 Jan 2024 Submission under peer review 12 Jan 2024 Submission passed technical check 12 Jan 2024 Revision received 11 Jan 2024 Submission under peer review 18 Dec 2023 Submission passed technical check 18 Dec 2023 Revision received 17 Dec 2023 Submission under peer review 24 Oct 2023 Technical check Submission status Date Submission passed technical check 24 Oct 2023 Submission is under technical check 22 Oct 2023 Submission received Submission status Date Submission received 22 Oct 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Sun Feb 25 15:40:43 CST 2024, time=2024-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2149452, encodeId=054d214945294, content=审稿速度:4.0 | 投稿命中率:60.0 偏重的研究方向：神经 经验分享：第一投sci，觉得这个期刊效率非常高。 3月底第一次投，一个半月后返回大修。 5月底修回，2周后返回让改一些细节。修回后第二天就接受了。 总体来说效率很高，如果按照要求修改没有大问题就会接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88d28575577, createdName=ms1000001394515981, createdTime=Sun Jul 23 16:16:07 CST 2023, time=2023-07-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2127009, encodeId=9ca3212e009ca, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经 经验分享：第一投sci，觉得这个期刊效率非常高。 12月第一次投，一个月后返回大修。 2月返回，一个月后返回大修。 3月返回，大概2周左右返回改一些细节。修改后4.17号当天就接受了。总体来说效率很高，如果按照要求修改没有大问题就会接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95552384636, createdName=1231e57am12(暂无昵称), createdTime=Wed Apr 19 11:51:37 CST 2023, time=2023-04-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2171254, encodeId=431c21e125497, content=请问接受纯临床吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:22:49 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2164705, encodeId=3c432164e050c, content=偏重的研究方向：生物分子学 经验分享：您好，显示peer review是什么状态？是内审还是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Tue Oct 24 21:23:44 CST 2023, time=2023-10-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=892984, encodeId=b1ec89298493, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一篇神经系统肿瘤方向的文章，8月9日投的，第二天就是现实under review了，9月7日时，一审结束，给了major revised，两个月的修稿期限，大概花了一个月多点就修回，当天就under review，大概一周后就接受了，很有效率的一个杂志，提的问题也很专业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Mon Oct 19 10:10:58 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093515, encodeId=973f209351562, content=谨慎投，编辑没耐心，信息不回…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yZMXnmg6RUGAicEEt8IqCOInFUxNbFcNSyThIDK476tiapLZLsqHgCosjhQkpzP044YCTfP1KYt8P5ZuWm4FEib7g/132, createdBy=7aeb2065728, createdName=136****1486, createdTime=Wed Oct 12 23:27:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812708, encodeId=2d73812e08c7, content=外审后被拒稿了、但是给了相当多的修改意见主要是材料方法方面的补充、语言等问题。编辑也没有明确说修改后重投、是否可以修改重投呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJZVORj10DibMvxp2GMB6I9XFRMfAzM7gjxhBMLOj16qQdUB0FMNO42a7SnCCHOCCSx2OMWwzV2K5Q/132, createdBy=a1c25173107, createdName=洛宁迦, createdTime=Mon Aug 24 16:57:05 CST 2020, time=2020-08-24, status=1, ipAttribution=)]

2024-10-13 ms5000002052969284 来自安徽省

审稿速度:6.0
偏重的研究方向：神经
经验分享：2024年九月份投的，10月份才找到第一个审稿人，服了，怎么这么慢啊~

4 0

[GetPortalCommentsPageByObjectIdResponse(id=2230598, encodeId=67292230598d0, content=审稿速度:6.0 偏重的研究方向：神经 经验分享：2024年九月份投的，10月份才找到第一个审稿人，服了，怎么这么慢啊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18a99452737, createdName=ms5000002052969284, createdTime=Sun Oct 13 11:01:18 CST 2024, time=2024-10-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2220216, encodeId=90222220216c9, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：神经相关作用机制 经验分享：审稿较慢，但是修回之后，接受就很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e081658561, createdName=xixixi, createdTime=Thu Aug 15 10:52:03 CST 2024, time=2024-08-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2189283, encodeId=3da5218928320, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：小胶质细胞，脱髓鞘;生物分子学;神经 经验分享： Submission accepted 17 Jan 2024 Submission under peer review 12 Jan 2024 Submission passed technical check 12 Jan 2024 Revision received 11 Jan 2024 Submission under peer review 18 Dec 2023 Submission passed technical check 18 Dec 2023 Revision received 17 Dec 2023 Submission under peer review 24 Oct 2023 Technical check Submission status Date Submission passed technical check 24 Oct 2023 Submission is under technical check 22 Oct 2023 Submission received Submission status Date Submission received 22 Oct 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Sun Feb 25 15:40:43 CST 2024, time=2024-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2149452, encodeId=054d214945294, content=审稿速度:4.0 | 投稿命中率:60.0 偏重的研究方向：神经 经验分享：第一投sci，觉得这个期刊效率非常高。 3月底第一次投，一个半月后返回大修。 5月底修回，2周后返回让改一些细节。修回后第二天就接受了。 总体来说效率很高，如果按照要求修改没有大问题就会接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88d28575577, createdName=ms1000001394515981, createdTime=Sun Jul 23 16:16:07 CST 2023, time=2023-07-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2127009, encodeId=9ca3212e009ca, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经 经验分享：第一投sci，觉得这个期刊效率非常高。 12月第一次投，一个月后返回大修。 2月返回，一个月后返回大修。 3月返回，大概2周左右返回改一些细节。修改后4.17号当天就接受了。总体来说效率很高，如果按照要求修改没有大问题就会接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95552384636, createdName=1231e57am12(暂无昵称), createdTime=Wed Apr 19 11:51:37 CST 2023, time=2023-04-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2171254, encodeId=431c21e125497, content=请问接受纯临床吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:22:49 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2164705, encodeId=3c432164e050c, content=偏重的研究方向：生物分子学 经验分享：您好，显示peer review是什么状态？是内审还是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Tue Oct 24 21:23:44 CST 2023, time=2023-10-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=892984, encodeId=b1ec89298493, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一篇神经系统肿瘤方向的文章，8月9日投的，第二天就是现实under review了，9月7日时，一审结束，给了major revised，两个月的修稿期限，大概花了一个月多点就修回，当天就under review，大概一周后就接受了，很有效率的一个杂志，提的问题也很专业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Mon Oct 19 10:10:58 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093515, encodeId=973f209351562, content=谨慎投，编辑没耐心，信息不回…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yZMXnmg6RUGAicEEt8IqCOInFUxNbFcNSyThIDK476tiapLZLsqHgCosjhQkpzP044YCTfP1KYt8P5ZuWm4FEib7g/132, createdBy=7aeb2065728, createdName=136****1486, createdTime=Wed Oct 12 23:27:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812708, encodeId=2d73812e08c7, content=外审后被拒稿了、但是给了相当多的修改意见主要是材料方法方面的补充、语言等问题。编辑也没有明确说修改后重投、是否可以修改重投呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJZVORj10DibMvxp2GMB6I9XFRMfAzM7gjxhBMLOj16qQdUB0FMNO42a7SnCCHOCCSx2OMWwzV2K5Q/132, createdBy=a1c25173107, createdName=洛宁迦, createdTime=Mon Aug 24 16:57:05 CST 2020, time=2020-08-24, status=1, ipAttribution=)]

2024-08-15 xixixi 来自湖南省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：神经相关作用机制
经验分享：审稿较慢，但是修回之后，接受就很快

46 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2230598, encodeId=67292230598d0, content=审稿速度:6.0 偏重的研究方向：神经 经验分享：2024年九月份投的，10月份才找到第一个审稿人，服了，怎么这么慢啊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18a99452737, createdName=ms5000002052969284, createdTime=Sun Oct 13 11:01:18 CST 2024, time=2024-10-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2220216, encodeId=90222220216c9, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：神经相关作用机制 经验分享：审稿较慢，但是修回之后，接受就很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e081658561, createdName=xixixi, createdTime=Thu Aug 15 10:52:03 CST 2024, time=2024-08-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2189283, encodeId=3da5218928320, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：小胶质细胞，脱髓鞘;生物分子学;神经 经验分享： Submission accepted 17 Jan 2024 Submission under peer review 12 Jan 2024 Submission passed technical check 12 Jan 2024 Revision received 11 Jan 2024 Submission under peer review 18 Dec 2023 Submission passed technical check 18 Dec 2023 Revision received 17 Dec 2023 Submission under peer review 24 Oct 2023 Technical check Submission status Date Submission passed technical check 24 Oct 2023 Submission is under technical check 22 Oct 2023 Submission received Submission status Date Submission received 22 Oct 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Sun Feb 25 15:40:43 CST 2024, time=2024-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2149452, encodeId=054d214945294, content=审稿速度:4.0 | 投稿命中率:60.0 偏重的研究方向：神经 经验分享：第一投sci，觉得这个期刊效率非常高。 3月底第一次投，一个半月后返回大修。 5月底修回，2周后返回让改一些细节。修回后第二天就接受了。 总体来说效率很高，如果按照要求修改没有大问题就会接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88d28575577, createdName=ms1000001394515981, createdTime=Sun Jul 23 16:16:07 CST 2023, time=2023-07-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2127009, encodeId=9ca3212e009ca, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经 经验分享：第一投sci，觉得这个期刊效率非常高。 12月第一次投，一个月后返回大修。 2月返回，一个月后返回大修。 3月返回，大概2周左右返回改一些细节。修改后4.17号当天就接受了。总体来说效率很高，如果按照要求修改没有大问题就会接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95552384636, createdName=1231e57am12(暂无昵称), createdTime=Wed Apr 19 11:51:37 CST 2023, time=2023-04-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2171254, encodeId=431c21e125497, content=请问接受纯临床吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:22:49 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2164705, encodeId=3c432164e050c, content=偏重的研究方向：生物分子学 经验分享：您好，显示peer review是什么状态？是内审还是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Tue Oct 24 21:23:44 CST 2023, time=2023-10-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=892984, encodeId=b1ec89298493, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一篇神经系统肿瘤方向的文章，8月9日投的，第二天就是现实under review了，9月7日时，一审结束，给了major revised，两个月的修稿期限，大概花了一个月多点就修回，当天就under review，大概一周后就接受了，很有效率的一个杂志，提的问题也很专业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Mon Oct 19 10:10:58 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093515, encodeId=973f209351562, content=谨慎投，编辑没耐心，信息不回…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yZMXnmg6RUGAicEEt8IqCOInFUxNbFcNSyThIDK476tiapLZLsqHgCosjhQkpzP044YCTfP1KYt8P5ZuWm4FEib7g/132, createdBy=7aeb2065728, createdName=136****1486, createdTime=Wed Oct 12 23:27:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812708, encodeId=2d73812e08c7, content=外审后被拒稿了、但是给了相当多的修改意见主要是材料方法方面的补充、语言等问题。编辑也没有明确说修改后重投、是否可以修改重投呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJZVORj10DibMvxp2GMB6I9XFRMfAzM7gjxhBMLOj16qQdUB0FMNO42a7SnCCHOCCSx2OMWwzV2K5Q/132, createdBy=a1c25173107, createdName=洛宁迦, createdTime=Mon Aug 24 16:57:05 CST 2020, time=2020-08-24, status=1, ipAttribution=)]

2024-02-25 ms5000001632088774 来自山东省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：小胶质细胞，脱髓鞘;生物分子学;神经
经验分享：
Submission accepted
17 Jan 2024
Submission under peer review
12 Jan 2024
Submission passed technical check
12 Jan 2024
Revision received
11 Jan 2024
Submission under peer review
18 Dec 2023
Submission passed technical check
18 Dec 2023
Revision received
17 Dec 2023
Submission under peer review
24 Oct 2023
Technical check
Submission status Date
Submission passed technical check
24 Oct 2023
Submission is under technical check
22 Oct 2023
Submission received
Submission status Date
Submission received
22 Oct 2023

85 0

[GetPortalCommentsPageByObjectIdResponse(id=2230598, encodeId=67292230598d0, content=审稿速度:6.0 偏重的研究方向：神经 经验分享：2024年九月份投的，10月份才找到第一个审稿人，服了，怎么这么慢啊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18a99452737, createdName=ms5000002052969284, createdTime=Sun Oct 13 11:01:18 CST 2024, time=2024-10-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2220216, encodeId=90222220216c9, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：神经相关作用机制 经验分享：审稿较慢，但是修回之后，接受就很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e081658561, createdName=xixixi, createdTime=Thu Aug 15 10:52:03 CST 2024, time=2024-08-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2189283, encodeId=3da5218928320, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：小胶质细胞，脱髓鞘;生物分子学;神经 经验分享： Submission accepted 17 Jan 2024 Submission under peer review 12 Jan 2024 Submission passed technical check 12 Jan 2024 Revision received 11 Jan 2024 Submission under peer review 18 Dec 2023 Submission passed technical check 18 Dec 2023 Revision received 17 Dec 2023 Submission under peer review 24 Oct 2023 Technical check Submission status Date Submission passed technical check 24 Oct 2023 Submission is under technical check 22 Oct 2023 Submission received Submission status Date Submission received 22 Oct 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Sun Feb 25 15:40:43 CST 2024, time=2024-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2149452, encodeId=054d214945294, content=审稿速度:4.0 | 投稿命中率:60.0 偏重的研究方向：神经 经验分享：第一投sci，觉得这个期刊效率非常高。 3月底第一次投，一个半月后返回大修。 5月底修回，2周后返回让改一些细节。修回后第二天就接受了。 总体来说效率很高，如果按照要求修改没有大问题就会接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88d28575577, createdName=ms1000001394515981, createdTime=Sun Jul 23 16:16:07 CST 2023, time=2023-07-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2127009, encodeId=9ca3212e009ca, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经 经验分享：第一投sci，觉得这个期刊效率非常高。 12月第一次投，一个月后返回大修。 2月返回，一个月后返回大修。 3月返回，大概2周左右返回改一些细节。修改后4.17号当天就接受了。总体来说效率很高，如果按照要求修改没有大问题就会接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95552384636, createdName=1231e57am12(暂无昵称), createdTime=Wed Apr 19 11:51:37 CST 2023, time=2023-04-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2171254, encodeId=431c21e125497, content=请问接受纯临床吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:22:49 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2164705, encodeId=3c432164e050c, content=偏重的研究方向：生物分子学 经验分享：您好，显示peer review是什么状态？是内审还是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Tue Oct 24 21:23:44 CST 2023, time=2023-10-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=892984, encodeId=b1ec89298493, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一篇神经系统肿瘤方向的文章，8月9日投的，第二天就是现实under review了，9月7日时，一审结束，给了major revised，两个月的修稿期限，大概花了一个月多点就修回，当天就under review，大概一周后就接受了，很有效率的一个杂志，提的问题也很专业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Mon Oct 19 10:10:58 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093515, encodeId=973f209351562, content=谨慎投，编辑没耐心，信息不回…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yZMXnmg6RUGAicEEt8IqCOInFUxNbFcNSyThIDK476tiapLZLsqHgCosjhQkpzP044YCTfP1KYt8P5ZuWm4FEib7g/132, createdBy=7aeb2065728, createdName=136****1486, createdTime=Wed Oct 12 23:27:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812708, encodeId=2d73812e08c7, content=外审后被拒稿了、但是给了相当多的修改意见主要是材料方法方面的补充、语言等问题。编辑也没有明确说修改后重投、是否可以修改重投呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJZVORj10DibMvxp2GMB6I9XFRMfAzM7gjxhBMLOj16qQdUB0FMNO42a7SnCCHOCCSx2OMWwzV2K5Q/132, createdBy=a1c25173107, createdName=洛宁迦, createdTime=Mon Aug 24 16:57:05 CST 2020, time=2020-08-24, status=1, ipAttribution=)]

2023-07-23 ms1000001394515981 来自河北省

审稿速度:4.0 | 投稿命中率:60.0
偏重的研究方向：神经
经验分享：第一投sci，觉得这个期刊效率非常高。
3月底第一次投，一个半月后返回大修。
5月底修回，2周后返回让改一些细节。修回后第二天就接受了。
总体来说效率很高，如果按照要求修改没有大问题就会接受。

100 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2230598, encodeId=67292230598d0, content=审稿速度:6.0 偏重的研究方向：神经 经验分享：2024年九月份投的，10月份才找到第一个审稿人，服了，怎么这么慢啊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18a99452737, createdName=ms5000002052969284, createdTime=Sun Oct 13 11:01:18 CST 2024, time=2024-10-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2220216, encodeId=90222220216c9, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：神经相关作用机制 经验分享：审稿较慢，但是修回之后，接受就很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e081658561, createdName=xixixi, createdTime=Thu Aug 15 10:52:03 CST 2024, time=2024-08-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2189283, encodeId=3da5218928320, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：小胶质细胞，脱髓鞘;生物分子学;神经 经验分享： Submission accepted 17 Jan 2024 Submission under peer review 12 Jan 2024 Submission passed technical check 12 Jan 2024 Revision received 11 Jan 2024 Submission under peer review 18 Dec 2023 Submission passed technical check 18 Dec 2023 Revision received 17 Dec 2023 Submission under peer review 24 Oct 2023 Technical check Submission status Date Submission passed technical check 24 Oct 2023 Submission is under technical check 22 Oct 2023 Submission received Submission status Date Submission received 22 Oct 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Sun Feb 25 15:40:43 CST 2024, time=2024-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2149452, encodeId=054d214945294, content=审稿速度:4.0 | 投稿命中率:60.0 偏重的研究方向：神经 经验分享：第一投sci，觉得这个期刊效率非常高。 3月底第一次投，一个半月后返回大修。 5月底修回，2周后返回让改一些细节。修回后第二天就接受了。 总体来说效率很高，如果按照要求修改没有大问题就会接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88d28575577, createdName=ms1000001394515981, createdTime=Sun Jul 23 16:16:07 CST 2023, time=2023-07-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2127009, encodeId=9ca3212e009ca, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经 经验分享：第一投sci，觉得这个期刊效率非常高。 12月第一次投，一个月后返回大修。 2月返回，一个月后返回大修。 3月返回，大概2周左右返回改一些细节。修改后4.17号当天就接受了。总体来说效率很高，如果按照要求修改没有大问题就会接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95552384636, createdName=1231e57am12(暂无昵称), createdTime=Wed Apr 19 11:51:37 CST 2023, time=2023-04-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2171254, encodeId=431c21e125497, content=请问接受纯临床吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:22:49 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2164705, encodeId=3c432164e050c, content=偏重的研究方向：生物分子学 经验分享：您好，显示peer review是什么状态？是内审还是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Tue Oct 24 21:23:44 CST 2023, time=2023-10-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=892984, encodeId=b1ec89298493, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一篇神经系统肿瘤方向的文章，8月9日投的，第二天就是现实under review了，9月7日时，一审结束，给了major revised，两个月的修稿期限，大概花了一个月多点就修回，当天就under review，大概一周后就接受了，很有效率的一个杂志，提的问题也很专业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Mon Oct 19 10:10:58 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093515, encodeId=973f209351562, content=谨慎投，编辑没耐心，信息不回…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yZMXnmg6RUGAicEEt8IqCOInFUxNbFcNSyThIDK476tiapLZLsqHgCosjhQkpzP044YCTfP1KYt8P5ZuWm4FEib7g/132, createdBy=7aeb2065728, createdName=136****1486, createdTime=Wed Oct 12 23:27:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812708, encodeId=2d73812e08c7, content=外审后被拒稿了、但是给了相当多的修改意见主要是材料方法方面的补充、语言等问题。编辑也没有明确说修改后重投、是否可以修改重投呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJZVORj10DibMvxp2GMB6I9XFRMfAzM7gjxhBMLOj16qQdUB0FMNO42a7SnCCHOCCSx2OMWwzV2K5Q/132, createdBy=a1c25173107, createdName=洛宁迦, createdTime=Mon Aug 24 16:57:05 CST 2020, time=2020-08-24, status=1, ipAttribution=)]

2023-04-19 1231e57am12(暂无昵称) 来自重庆

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：神经
经验分享：第一投sci，觉得这个期刊效率非常高。 12月第一次投，一个月后返回大修。 2月返回，一个月后返回大修。 3月返回，大概2周左右返回改一些细节。修改后4.17号当天就接受了。总体来说效率很高，如果按照要求修改没有大问题就会接受。

101 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2230598, encodeId=67292230598d0, content=审稿速度:6.0 偏重的研究方向：神经 经验分享：2024年九月份投的，10月份才找到第一个审稿人，服了，怎么这么慢啊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18a99452737, createdName=ms5000002052969284, createdTime=Sun Oct 13 11:01:18 CST 2024, time=2024-10-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2220216, encodeId=90222220216c9, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：神经相关作用机制 经验分享：审稿较慢，但是修回之后，接受就很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e081658561, createdName=xixixi, createdTime=Thu Aug 15 10:52:03 CST 2024, time=2024-08-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2189283, encodeId=3da5218928320, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：小胶质细胞，脱髓鞘;生物分子学;神经 经验分享： Submission accepted 17 Jan 2024 Submission under peer review 12 Jan 2024 Submission passed technical check 12 Jan 2024 Revision received 11 Jan 2024 Submission under peer review 18 Dec 2023 Submission passed technical check 18 Dec 2023 Revision received 17 Dec 2023 Submission under peer review 24 Oct 2023 Technical check Submission status Date Submission passed technical check 24 Oct 2023 Submission is under technical check 22 Oct 2023 Submission received Submission status Date Submission received 22 Oct 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Sun Feb 25 15:40:43 CST 2024, time=2024-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2149452, encodeId=054d214945294, content=审稿速度:4.0 | 投稿命中率:60.0 偏重的研究方向：神经 经验分享：第一投sci，觉得这个期刊效率非常高。 3月底第一次投，一个半月后返回大修。 5月底修回，2周后返回让改一些细节。修回后第二天就接受了。 总体来说效率很高，如果按照要求修改没有大问题就会接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88d28575577, createdName=ms1000001394515981, createdTime=Sun Jul 23 16:16:07 CST 2023, time=2023-07-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2127009, encodeId=9ca3212e009ca, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经 经验分享：第一投sci，觉得这个期刊效率非常高。 12月第一次投，一个月后返回大修。 2月返回，一个月后返回大修。 3月返回，大概2周左右返回改一些细节。修改后4.17号当天就接受了。总体来说效率很高，如果按照要求修改没有大问题就会接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95552384636, createdName=1231e57am12(暂无昵称), createdTime=Wed Apr 19 11:51:37 CST 2023, time=2023-04-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2171254, encodeId=431c21e125497, content=请问接受纯临床吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:22:49 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2164705, encodeId=3c432164e050c, content=偏重的研究方向：生物分子学 经验分享：您好，显示peer review是什么状态？是内审还是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Tue Oct 24 21:23:44 CST 2023, time=2023-10-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=892984, encodeId=b1ec89298493, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一篇神经系统肿瘤方向的文章，8月9日投的，第二天就是现实under review了，9月7日时，一审结束，给了major revised，两个月的修稿期限，大概花了一个月多点就修回，当天就under review，大概一周后就接受了，很有效率的一个杂志，提的问题也很专业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Mon Oct 19 10:10:58 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093515, encodeId=973f209351562, content=谨慎投，编辑没耐心，信息不回…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yZMXnmg6RUGAicEEt8IqCOInFUxNbFcNSyThIDK476tiapLZLsqHgCosjhQkpzP044YCTfP1KYt8P5ZuWm4FEib7g/132, createdBy=7aeb2065728, createdName=136****1486, createdTime=Wed Oct 12 23:27:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812708, encodeId=2d73812e08c7, content=外审后被拒稿了、但是给了相当多的修改意见主要是材料方法方面的补充、语言等问题。编辑也没有明确说修改后重投、是否可以修改重投呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJZVORj10DibMvxp2GMB6I9XFRMfAzM7gjxhBMLOj16qQdUB0FMNO42a7SnCCHOCCSx2OMWwzV2K5Q/132, createdBy=a1c25173107, createdName=洛宁迦, createdTime=Mon Aug 24 16:57:05 CST 2020, time=2020-08-24, status=1, ipAttribution=)]

2023-11-27 ms7000001113449944 来自海南省

请问接受纯临床吗

86 0

[GetPortalCommentsPageByObjectIdResponse(id=2230598, encodeId=67292230598d0, content=审稿速度:6.0 偏重的研究方向：神经 经验分享：2024年九月份投的，10月份才找到第一个审稿人，服了，怎么这么慢啊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18a99452737, createdName=ms5000002052969284, createdTime=Sun Oct 13 11:01:18 CST 2024, time=2024-10-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2220216, encodeId=90222220216c9, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：神经相关作用机制 经验分享：审稿较慢，但是修回之后，接受就很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e081658561, createdName=xixixi, createdTime=Thu Aug 15 10:52:03 CST 2024, time=2024-08-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2189283, encodeId=3da5218928320, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：小胶质细胞，脱髓鞘;生物分子学;神经 经验分享： Submission accepted 17 Jan 2024 Submission under peer review 12 Jan 2024 Submission passed technical check 12 Jan 2024 Revision received 11 Jan 2024 Submission under peer review 18 Dec 2023 Submission passed technical check 18 Dec 2023 Revision received 17 Dec 2023 Submission under peer review 24 Oct 2023 Technical check Submission status Date Submission passed technical check 24 Oct 2023 Submission is under technical check 22 Oct 2023 Submission received Submission status Date Submission received 22 Oct 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Sun Feb 25 15:40:43 CST 2024, time=2024-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2149452, encodeId=054d214945294, content=审稿速度:4.0 | 投稿命中率:60.0 偏重的研究方向：神经 经验分享：第一投sci，觉得这个期刊效率非常高。 3月底第一次投，一个半月后返回大修。 5月底修回，2周后返回让改一些细节。修回后第二天就接受了。 总体来说效率很高，如果按照要求修改没有大问题就会接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88d28575577, createdName=ms1000001394515981, createdTime=Sun Jul 23 16:16:07 CST 2023, time=2023-07-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2127009, encodeId=9ca3212e009ca, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经 经验分享：第一投sci，觉得这个期刊效率非常高。 12月第一次投，一个月后返回大修。 2月返回，一个月后返回大修。 3月返回，大概2周左右返回改一些细节。修改后4.17号当天就接受了。总体来说效率很高，如果按照要求修改没有大问题就会接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95552384636, createdName=1231e57am12(暂无昵称), createdTime=Wed Apr 19 11:51:37 CST 2023, time=2023-04-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2171254, encodeId=431c21e125497, content=请问接受纯临床吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:22:49 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2164705, encodeId=3c432164e050c, content=偏重的研究方向：生物分子学 经验分享：您好，显示peer review是什么状态？是内审还是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Tue Oct 24 21:23:44 CST 2023, time=2023-10-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=892984, encodeId=b1ec89298493, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一篇神经系统肿瘤方向的文章，8月9日投的，第二天就是现实under review了，9月7日时，一审结束，给了major revised，两个月的修稿期限，大概花了一个月多点就修回，当天就under review，大概一周后就接受了，很有效率的一个杂志，提的问题也很专业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Mon Oct 19 10:10:58 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093515, encodeId=973f209351562, content=谨慎投，编辑没耐心，信息不回…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yZMXnmg6RUGAicEEt8IqCOInFUxNbFcNSyThIDK476tiapLZLsqHgCosjhQkpzP044YCTfP1KYt8P5ZuWm4FEib7g/132, createdBy=7aeb2065728, createdName=136****1486, createdTime=Wed Oct 12 23:27:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812708, encodeId=2d73812e08c7, content=外审后被拒稿了、但是给了相当多的修改意见主要是材料方法方面的补充、语言等问题。编辑也没有明确说修改后重投、是否可以修改重投呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJZVORj10DibMvxp2GMB6I9XFRMfAzM7gjxhBMLOj16qQdUB0FMNO42a7SnCCHOCCSx2OMWwzV2K5Q/132, createdBy=a1c25173107, createdName=洛宁迦, createdTime=Mon Aug 24 16:57:05 CST 2020, time=2020-08-24, status=1, ipAttribution=)]

2023-10-24 ms5000001632088774 来自湖南省

偏重的研究方向：生物分子学
经验分享：您好，显示peer review是什么状态？是内审还是外审?

106 0

[GetPortalCommentsPageByObjectIdResponse(id=2230598, encodeId=67292230598d0, content=审稿速度:6.0 偏重的研究方向：神经 经验分享：2024年九月份投的，10月份才找到第一个审稿人，服了，怎么这么慢啊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18a99452737, createdName=ms5000002052969284, createdTime=Sun Oct 13 11:01:18 CST 2024, time=2024-10-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2220216, encodeId=90222220216c9, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：神经相关作用机制 经验分享：审稿较慢，但是修回之后，接受就很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e081658561, createdName=xixixi, createdTime=Thu Aug 15 10:52:03 CST 2024, time=2024-08-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2189283, encodeId=3da5218928320, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：小胶质细胞，脱髓鞘;生物分子学;神经 经验分享： Submission accepted 17 Jan 2024 Submission under peer review 12 Jan 2024 Submission passed technical check 12 Jan 2024 Revision received 11 Jan 2024 Submission under peer review 18 Dec 2023 Submission passed technical check 18 Dec 2023 Revision received 17 Dec 2023 Submission under peer review 24 Oct 2023 Technical check Submission status Date Submission passed technical check 24 Oct 2023 Submission is under technical check 22 Oct 2023 Submission received Submission status Date Submission received 22 Oct 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Sun Feb 25 15:40:43 CST 2024, time=2024-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2149452, encodeId=054d214945294, content=审稿速度:4.0 | 投稿命中率:60.0 偏重的研究方向：神经 经验分享：第一投sci，觉得这个期刊效率非常高。 3月底第一次投，一个半月后返回大修。 5月底修回，2周后返回让改一些细节。修回后第二天就接受了。 总体来说效率很高，如果按照要求修改没有大问题就会接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88d28575577, createdName=ms1000001394515981, createdTime=Sun Jul 23 16:16:07 CST 2023, time=2023-07-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2127009, encodeId=9ca3212e009ca, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经 经验分享：第一投sci，觉得这个期刊效率非常高。 12月第一次投，一个月后返回大修。 2月返回，一个月后返回大修。 3月返回，大概2周左右返回改一些细节。修改后4.17号当天就接受了。总体来说效率很高，如果按照要求修改没有大问题就会接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95552384636, createdName=1231e57am12(暂无昵称), createdTime=Wed Apr 19 11:51:37 CST 2023, time=2023-04-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2171254, encodeId=431c21e125497, content=请问接受纯临床吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:22:49 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2164705, encodeId=3c432164e050c, content=偏重的研究方向：生物分子学 经验分享：您好，显示peer review是什么状态？是内审还是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Tue Oct 24 21:23:44 CST 2023, time=2023-10-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=892984, encodeId=b1ec89298493, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一篇神经系统肿瘤方向的文章，8月9日投的，第二天就是现实under review了，9月7日时，一审结束，给了major revised，两个月的修稿期限，大概花了一个月多点就修回，当天就under review，大概一周后就接受了，很有效率的一个杂志，提的问题也很专业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Mon Oct 19 10:10:58 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093515, encodeId=973f209351562, content=谨慎投，编辑没耐心，信息不回…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yZMXnmg6RUGAicEEt8IqCOInFUxNbFcNSyThIDK476tiapLZLsqHgCosjhQkpzP044YCTfP1KYt8P5ZuWm4FEib7g/132, createdBy=7aeb2065728, createdName=136****1486, createdTime=Wed Oct 12 23:27:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812708, encodeId=2d73812e08c7, content=外审后被拒稿了、但是给了相当多的修改意见主要是材料方法方面的补充、语言等问题。编辑也没有明确说修改后重投、是否可以修改重投呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJZVORj10DibMvxp2GMB6I9XFRMfAzM7gjxhBMLOj16qQdUB0FMNO42a7SnCCHOCCSx2OMWwzV2K5Q/132, createdBy=a1c25173107, createdName=洛宁迦, createdTime=Mon Aug 24 16:57:05 CST 2020, time=2020-08-24, status=1, ipAttribution=)]

2020-10-19 1424056585

审稿速度:3.0 | 投稿命中率:50.0
经验分享：投了一篇神经系统肿瘤方向的文章，8月9日投的，第二天就是现实under review了，9月7日时，一审结束，给了major revised，两个月的修稿期限，大概花了一个月多点就修回，当天就under review，大概一周后就接受了，很有效率的一个杂志，提的问题也很专业…

208 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2230598, encodeId=67292230598d0, content=审稿速度:6.0 偏重的研究方向：神经 经验分享：2024年九月份投的，10月份才找到第一个审稿人，服了，怎么这么慢啊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18a99452737, createdName=ms5000002052969284, createdTime=Sun Oct 13 11:01:18 CST 2024, time=2024-10-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2220216, encodeId=90222220216c9, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：神经相关作用机制 经验分享：审稿较慢，但是修回之后，接受就很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e081658561, createdName=xixixi, createdTime=Thu Aug 15 10:52:03 CST 2024, time=2024-08-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2189283, encodeId=3da5218928320, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：小胶质细胞，脱髓鞘;生物分子学;神经 经验分享： Submission accepted 17 Jan 2024 Submission under peer review 12 Jan 2024 Submission passed technical check 12 Jan 2024 Revision received 11 Jan 2024 Submission under peer review 18 Dec 2023 Submission passed technical check 18 Dec 2023 Revision received 17 Dec 2023 Submission under peer review 24 Oct 2023 Technical check Submission status Date Submission passed technical check 24 Oct 2023 Submission is under technical check 22 Oct 2023 Submission received Submission status Date Submission received 22 Oct 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Sun Feb 25 15:40:43 CST 2024, time=2024-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2149452, encodeId=054d214945294, content=审稿速度:4.0 | 投稿命中率:60.0 偏重的研究方向：神经 经验分享：第一投sci，觉得这个期刊效率非常高。 3月底第一次投，一个半月后返回大修。 5月底修回，2周后返回让改一些细节。修回后第二天就接受了。 总体来说效率很高，如果按照要求修改没有大问题就会接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88d28575577, createdName=ms1000001394515981, createdTime=Sun Jul 23 16:16:07 CST 2023, time=2023-07-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2127009, encodeId=9ca3212e009ca, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经 经验分享：第一投sci，觉得这个期刊效率非常高。 12月第一次投，一个月后返回大修。 2月返回，一个月后返回大修。 3月返回，大概2周左右返回改一些细节。修改后4.17号当天就接受了。总体来说效率很高，如果按照要求修改没有大问题就会接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95552384636, createdName=1231e57am12(暂无昵称), createdTime=Wed Apr 19 11:51:37 CST 2023, time=2023-04-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2171254, encodeId=431c21e125497, content=请问接受纯临床吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:22:49 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2164705, encodeId=3c432164e050c, content=偏重的研究方向：生物分子学 经验分享：您好，显示peer review是什么状态？是内审还是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Tue Oct 24 21:23:44 CST 2023, time=2023-10-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=892984, encodeId=b1ec89298493, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一篇神经系统肿瘤方向的文章，8月9日投的，第二天就是现实under review了，9月7日时，一审结束，给了major revised，两个月的修稿期限，大概花了一个月多点就修回，当天就under review，大概一周后就接受了，很有效率的一个杂志，提的问题也很专业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Mon Oct 19 10:10:58 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093515, encodeId=973f209351562, content=谨慎投，编辑没耐心，信息不回…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yZMXnmg6RUGAicEEt8IqCOInFUxNbFcNSyThIDK476tiapLZLsqHgCosjhQkpzP044YCTfP1KYt8P5ZuWm4FEib7g/132, createdBy=7aeb2065728, createdName=136****1486, createdTime=Wed Oct 12 23:27:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812708, encodeId=2d73812e08c7, content=外审后被拒稿了、但是给了相当多的修改意见主要是材料方法方面的补充、语言等问题。编辑也没有明确说修改后重投、是否可以修改重投呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJZVORj10DibMvxp2GMB6I9XFRMfAzM7gjxhBMLOj16qQdUB0FMNO42a7SnCCHOCCSx2OMWwzV2K5Q/132, createdBy=a1c25173107, createdName=洛宁迦, createdTime=Mon Aug 24 16:57:05 CST 2020, time=2020-08-24, status=1, ipAttribution=)]

2022-10-12 136****1486

谨慎投，编辑没耐心，信息不回…

112 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2230598, encodeId=67292230598d0, content=审稿速度:6.0 偏重的研究方向：神经 经验分享：2024年九月份投的，10月份才找到第一个审稿人，服了，怎么这么慢啊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18a99452737, createdName=ms5000002052969284, createdTime=Sun Oct 13 11:01:18 CST 2024, time=2024-10-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2220216, encodeId=90222220216c9, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：神经相关作用机制 经验分享：审稿较慢，但是修回之后，接受就很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e081658561, createdName=xixixi, createdTime=Thu Aug 15 10:52:03 CST 2024, time=2024-08-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2189283, encodeId=3da5218928320, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：小胶质细胞，脱髓鞘;生物分子学;神经 经验分享： Submission accepted 17 Jan 2024 Submission under peer review 12 Jan 2024 Submission passed technical check 12 Jan 2024 Revision received 11 Jan 2024 Submission under peer review 18 Dec 2023 Submission passed technical check 18 Dec 2023 Revision received 17 Dec 2023 Submission under peer review 24 Oct 2023 Technical check Submission status Date Submission passed technical check 24 Oct 2023 Submission is under technical check 22 Oct 2023 Submission received Submission status Date Submission received 22 Oct 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Sun Feb 25 15:40:43 CST 2024, time=2024-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2149452, encodeId=054d214945294, content=审稿速度:4.0 | 投稿命中率:60.0 偏重的研究方向：神经 经验分享：第一投sci，觉得这个期刊效率非常高。 3月底第一次投，一个半月后返回大修。 5月底修回，2周后返回让改一些细节。修回后第二天就接受了。 总体来说效率很高，如果按照要求修改没有大问题就会接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88d28575577, createdName=ms1000001394515981, createdTime=Sun Jul 23 16:16:07 CST 2023, time=2023-07-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2127009, encodeId=9ca3212e009ca, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经 经验分享：第一投sci，觉得这个期刊效率非常高。 12月第一次投，一个月后返回大修。 2月返回，一个月后返回大修。 3月返回，大概2周左右返回改一些细节。修改后4.17号当天就接受了。总体来说效率很高，如果按照要求修改没有大问题就会接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95552384636, createdName=1231e57am12(暂无昵称), createdTime=Wed Apr 19 11:51:37 CST 2023, time=2023-04-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2171254, encodeId=431c21e125497, content=请问接受纯临床吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:22:49 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2164705, encodeId=3c432164e050c, content=偏重的研究方向：生物分子学 经验分享：您好，显示peer review是什么状态？是内审还是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Tue Oct 24 21:23:44 CST 2023, time=2023-10-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=892984, encodeId=b1ec89298493, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一篇神经系统肿瘤方向的文章，8月9日投的，第二天就是现实under review了，9月7日时，一审结束，给了major revised，两个月的修稿期限，大概花了一个月多点就修回，当天就under review，大概一周后就接受了，很有效率的一个杂志，提的问题也很专业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Mon Oct 19 10:10:58 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093515, encodeId=973f209351562, content=谨慎投，编辑没耐心，信息不回…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yZMXnmg6RUGAicEEt8IqCOInFUxNbFcNSyThIDK476tiapLZLsqHgCosjhQkpzP044YCTfP1KYt8P5ZuWm4FEib7g/132, createdBy=7aeb2065728, createdName=136****1486, createdTime=Wed Oct 12 23:27:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812708, encodeId=2d73812e08c7, content=外审后被拒稿了、但是给了相当多的修改意见主要是材料方法方面的补充、语言等问题。编辑也没有明确说修改后重投、是否可以修改重投呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJZVORj10DibMvxp2GMB6I9XFRMfAzM7gjxhBMLOj16qQdUB0FMNO42a7SnCCHOCCSx2OMWwzV2K5Q/132, createdBy=a1c25173107, createdName=洛宁迦, createdTime=Mon Aug 24 16:57:05 CST 2020, time=2020-08-24, status=1, ipAttribution=)]

2020-08-24 洛宁迦

外审后被拒稿了、但是给了相当多的修改意见主要是材料方法方面的补充、语言等问题。编辑也没有明确说修改后重投、是否可以修改重投呀

234 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务